WINNIPEG, Aug. 29, 2019 /CNW/ - DELTA 9 CANNABIS INC., a
vertically integrated producer and seller of medical and retail use
cannabis products (TSXV: DN) (OTCQX: VRNDF) ("Delta 9" or the
"Company"), is pleased to announce that its Securities (as defined
below) will begin trading on the Toronto Stock Exchange ("TSX") as
of the opening of the market on September 3,
2019.
"With the increased visibility that trading on the TSX provides
to the retail and institutional investor base, the up listing will
help to increase trading liquidity and access a growing investor
base interested in the cannabis industry," said John Arbuthnot, founder and Chief Executive
Officer of the Company.
Upon listing on the TSX, the Securities will continue to trade
under the symbols "DN" for the common shares, "DN.WT." for the
common share purchase warrants expiring June
28, 2020, "DN.WT.A." for the common share purchase warrants
expiring July 17, 2022, and "DN.DB"
for the 8.5% unsecured convertible debentures of the Company
(collectively, the "Securities"). In conjunction with the
listing on the TSX, the Securities will be voluntarily delisted
from the TSX Venture Exchange prior to the commencement of trading
on September 3, 2019.
About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis
company focused on bringing the highest quality cannabis products
to market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech
Inc., is a licensed producer of medical and recreational cannabis
and operates an 80,000 square foot production facility
in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of
retail stores under the Delta 9 Cannabis Store brand. Delta 9's
shares trade on the TSX Venture Exchange under the symbol "DN" and
on the OTCQX under the symbol VRNDF. For more information, please
visit www.delta9.ca.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking
statements, which reflect the expectations of management regarding
the Company's future business plans and other matters.
Forward-looking statements consist of statements that are not
purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future.
Forward-looking statements in this news release include
statements relating the commencement of trading of the Securities
on the TSX on September 3,
2019. Such statements are subject to risks and
uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
statement, including that the TSX will not list
the Securities.
No assurance can be given that any of the events anticipated
by the forward-looking statements will occur or, if they do occur,
what benefits the Company will obtain from them. Readers are urged
to consider these factors carefully in evaluating the
forward-looking statements contained in this news release and are
cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by these
cautionary statements. These forward-looking statements are made as
of the date hereof and the Company disclaims any intent or
obligation to update publicly any forward-looking statements,
whether as a result of new information, future events or results or
otherwise, except as required by applicable securities
laws.
SOURCE Delta 9 Cannabis Inc.
